Adaptimmune ‘Neck And Neck’ For First Solid Tumor T-Cell Therapy Nod For Afami-Cel

Company Looks Beyond Small Sarcoma Market For Afamitresgene Autoleucel

 
• By Alaric DeArment
T Cell lymphocyte with receptors for cancer cell immunotherapy research 3D render
Adaptimmune is reporting initial data from the SPEARHEAD-1 study of afami-cel at ASCO in June • Source: Shutterstock

More from ASCO

More from Conferences